These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15113861)

  • 21. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
    Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
    Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.
    Fuqua SA; Schiff R; Parra I; Moore JT; Mohsin SK; Osborne CK; Clark GM; Allred DC
    Cancer Res; 2003 May; 63(10):2434-9. PubMed ID: 12750263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis.
    Pellikainen MJ; Pekola TT; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    J Clin Pathol; 2003 Mar; 56(3):214-20. PubMed ID: 12610102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical value of the wild-type estrogen receptor beta expression in breast cancer.
    Omoto Y; Inoue S; Ogawa S; Toyama T; Yamashita H; Muramatsu M; Kobayashi S; Iwase H
    Cancer Lett; 2001 Feb; 163(2):207-12. PubMed ID: 11165756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of estrogen receptor subtypes in breast tumorigenesis and progression.
    Sun W; Gu C; Xia M; Zhong G; Song H; Guo J
    Tumour Biol; 2014 Sep; 35(9):9111-7. PubMed ID: 25027393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression and prognostic significance of oestrogen receptor-alpha, oestrogen receptor-beta, and progesterone receptor in stage 1 adult-type granulosa cell tumour of the ovary.
    Hutton SM; Webster LR; Nielsen S; Leung Y; Stewart CJ
    Pathology; 2012 Dec; 44(7):611-6. PubMed ID: 23149378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of oestrogen receptor alpha (ERalpha) and beta (ERbeta), progesterone receptor A (PR-A) and B (PR-B) in endometrial carcinomas.
    Shabani N; Kuhn C; Kunze S; Schulze S; Mayr D; Dian D; Gingelmaier A; Schindlbeck C; Willgeroth F; Sommer H; Jeschke U; Friese K; Mylonas I
    Eur J Cancer; 2007 Nov; 43(16):2434-44. PubMed ID: 17911007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPARgamma expression in breast cancer: clinical value and correlation with ERbeta.
    Papadaki I; Mylona E; Giannopoulou I; Markaki S; Keramopoulos A; Nakopoulou L
    Histopathology; 2005 Jan; 46(1):37-42. PubMed ID: 15656884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
    Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
    BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer.
    De Stefano I; Zannoni GF; Prisco MG; Fagotti A; Tortorella L; Vizzielli G; Mencaglia L; Scambia G; Gallo D
    Gynecol Oncol; 2011 Sep; 122(3):573-9. PubMed ID: 21665249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A; Margaria E; Chiusa L
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma.
    Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS
    Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.
    Bièche I; Parfait B; Laurendeau I; Girault I; Vidaud M; Lidereau R
    Oncogene; 2001 Dec; 20(56):8109-15. PubMed ID: 11781824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers.
    Litwiniuk MM; Roznowski K; Filas V; Godlewski DD; Stawicka M; Kaleta R; Breborowicz J
    BMC Cancer; 2008 Apr; 8():100. PubMed ID: 18405391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile.
    Ceccarelli C; Santini D; Chieco P; Taffurelli M; Gamberini M; Pileri SA; Marrano D
    J Clin Pathol; 1998 Nov; 51(11):818-24. PubMed ID: 10193322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-erbB-2 onco-protein expression in breast cancer: relationship to tumour characteristics and short-term survival in Universiti Kebansaan Malaysia Medical Centre.
    Sharifah NA; Lee BR; Clarence-Ko CH; Tan GC; Shiran MS; Naqiyah I; Rohaizak M; Fuad I; Tamil AM
    Asian Pac J Cancer Prev; 2008; 9(4):663-70. PubMed ID: 19271345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Over-expression of c-erbB-2 correlates with nuclear morphometry and prognosis in breast carcinoma in Asian women.
    Selvarajan S; Wong KY; Khoo KS; Bay BH; Tan PH
    Pathology; 2006 Dec; 38(6):528-33. PubMed ID: 17393979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.
    El-Hafez AA; El Aaty Shawky A; Hasan B
    Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.
    Mylona E; Magkou C; Giannopoulou I; Agrogiannis G; Markaki S; Keramopoulos A; Nakopoulou L
    Breast Cancer Res; 2006; 8(5):R57. PubMed ID: 17032447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.